Today: 24 June 2026
Nasdaq edges lower in after-hours as AI chip fall spurs margin chatter
24 June 2026
2 mins read

US stock futures edge higher as Micron (NASDAQ:MU) draws AI spotlight

NEW YORK, June 24, 2026, 06:05 EDT

Nasdaq futures traded a bit higher but Dow futures dipped before the open.

Nasdaq 100 futures were up 0.41% early Wednesday at 05:40 a.m. EDT, bouncing after two days of tech losses. S&P 500 futures edged 0.09% higher. Dow futures fell 0.16%. All numbers are premarket, not the open. Source: Markets Insider.

NYSE scheduled a normal session, running from 9:30 a.m. to 4 p.m. ET. June 24 is not shown as a holiday on the exchange’s 2026 calendar.

Tech came off session lows Tuesday, but sellers still had control. The Philadelphia SE Semiconductor index dropped 7.9%. S&P 500 technology fell 3.7%. Nasdaq Composite was down 2.21%. Investors pulled money after fresh doubt over debt-driven AI spending. “Questions about all the spending” followed recent AI headlines, said Thomas Martin, senior portfolio manager at Globalt. Reuters

Micron Technology led premarket gains. Micron’s stock climbed 3.8% ahead of the bell, while Sandisk was up 3.5%. Both dropped about 13% last session. Micron is set to report earnings after markets close. Even with the recent drop, Micron is up 268% this year. “I think people are going to get the blowout quarter that they expect, but I don’t expect the stock to continue to rise,” said Jay Woods, chief market strategist at Freedom Capital Markets. Reuters

Micron matters on this move because it’s a direct read on AI. The Street isn’t just focused on demand now. There are fresh doubts about whether demand will stay strong enough to back the prices memory stocks have hit after the recent run.

Cerebras has lowered its margin forecast again. The AI chip company is guiding for full-year adjusted gross margins of 38% to 41%. That’s a step down from the 47% it posted in Q1. Nvidia is still in the mid-70% range. CFO Bob Komin said that relying on outside capacity “will depress core cloud and other services margin temporarily.” Reuters

FedEx shares fell 7% before the bell as the company’s Federal Express unit posted a 7.7% operating margin, down from 8.4% a year ago. FedEx has spun off its Freight business and faces calls to lift returns in its delivery operations. UPS remains the main comparison point for investors.

Fed stays front and center with new data coming. The Bureau of Economic Analysis will release the next personal consumption expenditures price index on June 25. The Fed tracks inflation with the PCE, which measures what people spend on goods and services. The latest April reading showed prices rising 3.8% from a year earlier.

Dollar stayed firm with investors sticking to safe-haven trades while U.S.-Iran talks are in focus. U.S. stock futures tacked on 0.1% to 0.4%, showing little movement in a quiet session worldwide. Oil lost over 1%. The dollar reached a one-year high against major currencies. “A sign of instability,” said Michael McCarthy at Moomoo Securities Australia of the recent swings. Reuters

Wednesday’s early gains may not last. Weak numbers from Micron, rising rate-hike odds, or fresh concern over the U.S.-Iran deal could push sellers back into crowded AI names. If PCE comes in strong on Thursday, it gets harder for investors to ignore.

Barclays and Stifel each boosted their S&P 500 year-end targets to 7,800 on Tuesday, citing solid earnings. Stifel’s Thomas Carroll noted “stock concentration sits at 40-year highs,” warning the rally needs participation beyond megacap tech if it’s going to spread out. Bullish positioning is still in place, but space is tighter. Reuters

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • SK Hynix Plans $29 Billion Nasdaq ADR Listing to Tap U.S. Investors
    June 24, 2026, 8:01 AM EDT. South Korea's SK Hynix, the world's second-largest chipmaker, plans to raise approximately $29 billion through an American Depositary Receipt (ADR) listing on Nasdaq, aiming for a July 10 debut. The offering includes 17.79 million new shares valued at around 45.45 trillion won ($29.65 billion). SK Hynix expects the U.S. listing to broaden its investor base and properly value its corporate worth amid soaring demand for AI-related memory chips. The company, holding about 60% of the high bandwidth memory (HBM) market, reported a 280% share price surge in 2024. Major banks including BofA Securities, Citigroup, Goldman Sachs, and JP Morgan are managing the sale. The expansion coincides with new manufacturing facilities planned in both South Korea and the U.S.
Samsung rally puts buyback plan under investor lens

Samsung rally puts buyback plan under investor lens

24 June 2026
Samsung Electronics soared 9.8% after announcing it may buy shares for employee stock pay, with media reporting a 90 trillion won plan—equal to 4.5% of common shares and nearly five times Wednesday’s trading volume—fueling a sharp rebound in both Samsung’s stock and the KOSPI after Tuesday’s selloff.
Backblaze rally leaves CoreWeave deal below stated price

Backblaze rally leaves CoreWeave deal below stated price

24 June 2026
Backblaze surged 43.6% after landing a $335 million CoreWeave contract—4.2 times its 2025 B2 Cloud Storage revenue—but the stock’s $213 million equity gain values the deal at just 63 cents per contract dollar, as investors weigh costs, timing, and potential dilution from CoreWeave warrants covering up to 7% of shares.
Quantinuum stock trades higher with QNT price moving well above reported revenue
Previous Story

Quantinuum stock trades higher with QNT price moving well above reported revenue

Pfizer (NYSE:PFE) churns as investors price in bigger cancer pipeline discount after Seagen drug miss
Next Story

Pfizer (NYSE:PFE) churns as investors price in bigger cancer pipeline discount after Seagen drug miss

Go toTop